Doctors may soon face requests to provide medical clearance for commercial space travelers and these decisions could impact the growth of the private space industry, according to a newanalysis.
Datamonitor, a New York-based market analysis firm, noted in a report, published March 2001, of an industry shift towards "high-barrier-to-entry generic products, " or specialty generic pharmaceuticals.